Human Nutrition and Metabolism Soy Protein Intake by Perimenopausal Women Does Not Affect Circulating Lipids and Lipoproteins or Coagulation and Fibrinolytic Factors 1 , 2

Soy protein favorably alters serum lipids and lipoproteins in hypercholesterolemic individuals, thereby reducing cardiovascular disease risk. The primary purpose was to determine the effect of soy protein (40 g/d) on circulating lipids and lipoproteins or coagulation and fibrinolytic factors in normocholesterolemic and mildly hypercholesterolemic perimenopausal women. We also determined the contribution of coagulation and fibrinolytic and other factors (e.g., body size and composition; serum estrogens, ferritin, iron; dietary intake) to lipid profiles. Subjects were randomly assigned to treatment: isoflavone-rich soy (n 5 24), isoflavone-poor soy (n 5 24), or whey control (n 5 21) protein. We measured circulating lipids and lipoproteins at baseline, wk 12 and wk 24, and coagulation/fibrinolytic factors at baseline and wk 24. Coagulation and fibrinolytic factors were not adversely affected by treatment. Treatment did not alter lipid profiles in mildly hypercholesterolemic (n 5 30) or in all subjects combined. Time significantly (P , 0.001) affected serum total cholesterol, triacylglycerol, LDL cholesterol and HDL cholesterol concentrations. We could not attribute changes over time to various factors, but at baseline accounted for 57% of the variability in HDL cholesterol (P # 0.0001) and for 50% in the total to HDL cholesterol ratio (P # 0.0001). Dietary vitamin E and % energy from fat had positive effects, whereas plasma plasminogen activator inhibitor-1, fibrinogen, body weight and serum ferritin had negative effects on HDL and total to HDL cholesterol. Isoflavone-rich or isoflavone-poor soy protein had no effect on lipid profiles or coagulation and fibrinolytic factors, whereas the effect of time suggested that the hormonal milieu during the menopausal transition may have overridden any detectable treatment effect on lipids. The relationship between coagulation factors and serum lipids should be examined further as indices of cardiovascular disease risk in midlife women. J. Nutr. 131: 2280–2287,

[1]  R. Muche,et al.  Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS) , 1994, European journal of clinical investigation.

[2]  R. Paffenbarger,et al.  Physical activity as an index of heart attack risk in college alumni. , 1978, American journal of epidemiology.

[3]  L. Guize,et al.  Menopause-related changes in lipoproteins and some other cardiovascular risk factors. , 1990, International journal of epidemiology.

[4]  G. Paragh,et al.  Serum Paraoxonase Activity Changes in Uremic and Kidney-Transplanted Patients , 1999, Nephron.

[5]  H. Chen,et al.  Serum high density lipoprotein cholesterol and factors influencing its level in healthy Chinese. , 1983, Atherosclerosis.

[6]  L. Beilin,et al.  Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. , 1998, The Journal of nutrition.

[7]  K. Hajjar,et al.  The role of lipoprotein(a) in atherogenesis and thrombosis. , 1996, Annual review of medicine.

[8]  C. Stehouwer,et al.  Impaired Procoagulant-anticoagulant Balance during Hormone Replacement Therapy? , 2000, Thrombosis and Haemostasis.

[9]  R. Rauramaa,et al.  Association of risk factors and body iron status to carotid atherosclerosis in middle-aged eastern Finnish men. , 1994, European heart journal.

[10]  J. Hilsted,et al.  Body composition in normal subjects: relation to lipid and glucose variables. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[11]  J. Keul,et al.  Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[12]  James W. Anderson,et al.  Meta-analysis of the effects of soy protein intake on serum lipids. , 1995, The New England journal of medicine.

[13]  A. Duncan,et al.  Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. , 2001, The American journal of clinical nutrition.

[14]  J. Cameron,et al.  Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. , 1999, The Journal of clinical endocrinology and metabolism.

[15]  J. Rapp,et al.  Effect of dietary lipid peroxides on metabolism of serum chylomicrons in rats. , 1993, The American journal of physiology.

[16]  A. Goldberg,et al.  Effects of diet on lipoprotein metabolism. , 1985, Annual review of nutrition.

[17]  Heikki Korpela,et al.  High Stored Iron Levels Are Associated With Excess Risk of Myocardial Infarction in Eastern Finnish Men , 1992, Circulation.

[18]  S. Kiechl,et al.  Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck Study. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  K. Koike,et al.  Perimenopausal changes in serum lipids and lipoproteins: a 7-year longitudinal study. , 1995, Maturitas.

[20]  W. Maxson,et al.  Estrogen Replacement Therapy , 1986, Clinical obstetrics and gynecology.

[21]  D. Alekel,et al.  Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. , 2000, The American journal of clinical nutrition.

[22]  H. Burger.  Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition—an analysis of FSH, oestradiol and inhibin , 1994 .

[23]  J. Erdman,et al.  Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. , 1998, The American journal of clinical nutrition.

[24]  L. Mannucci,et al.  Hypertriglyceridemia and regulation of fibrinolytic activity. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[25]  P. Kris-Etherton,et al.  Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[26]  J. Simons,et al.  Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. , 2000, The American journal of cardiology.

[27]  G. Burke,et al.  Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. , 1999, Menopause.

[28]  T. Kristensen,et al.  Plasma fibrinogen and ischemic heart disease risk factors. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[29]  G. Lowe,et al.  Effects of lipids and lipoproteins on thrombosis and rheology. , 1998, Atherosclerosis.

[30]  W. Koenig,et al.  Association Between Rheology and Components of Lipoproteins in Human Blood: Results From the MONICA Project , 1992, Circulation.

[31]  D. Jacobs,et al.  Plasma High‐density Lipoprotein Cholesterol: Association with Measurements of Body Mass The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[32]  G. Shen,et al.  Impact of antioxidants and HDL on glycated LDL-induced generation of fibrinolytic regulators from vascular endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[33]  L. Kuller,et al.  The epidemiology of serum sex hormones in postmenopausal women. , 1989, American journal of epidemiology.

[34]  H. Macdonald.  High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. , 1993, Circulation.

[35]  J. Crouse,et al.  A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. , 1999, Archives of internal medicine.

[36]  J. Salonen.  The role of iron as a cardiovascular risk factor , 1993 .

[37]  S. Marcovina,et al.  Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-I and B. , 1994, Clinical chemistry.

[38]  J. Loscalzo,et al.  Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque. , 1994, Atherosclerosis.

[39]  S. Thompson,et al.  Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. , 1996, Circulation.

[40]  A. Dart,et al.  Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[41]  K. Sakaibori,et al.  Serum cholesterol level in normal people: association of serum cholesterol level with age and relative body weight. , 1987, Japanese journal of medicine.

[42]  K. Matthews,et al.  Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. , 1994, Archives of internal medicine.

[43]  T. V. van Berkel,et al.  Scavenger Receptor Classes A and B: Their Roles in Atherogenesis and the Metabolism of Modified LDL and HDL , 2000, Annals of the New York Academy of Sciences.

[44]  J. Wilcox,et al.  Thrombotic mechanisms in atherosclerosis: potential impact of soy proteins. , 1995, The Journal of nutrition.

[45]  R. Stocker,et al.  Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis. , 2000, Free radical biology & medicine.